menu search

Eur/usd consolidates around 1.0810 as powell’s speech influences market sentiment

By RoboForex Analytical Department The EUR/USD currency pair is entering the final week of August in a phase <...

August 28, 2023, 8:07 pm

How gold price gets to $10k: brics expansion, gold-backed currency, monetary reset - willem middelkoop

(Kitco News) - The BRICS formal invitation of Argentina, Egypt, Ethiopia, Iran, the United Arab Emirates, and Saudi Arabia to join the bloc moves the ...

August 28, 2023, 7:53 pm

Crinetics pharmaceuticals: creating next-generation treatments in acromegaly

Crinetics Pharmaceuticals, Inc. is my latest long position. The company has two phase 3 data releases f...

August 28, 2023, 6:07 pm

Novocure shares plunge after its ovarian cancer treatment fails to meet goal

Novocure (NVCR) shares plunged 37.5% on Monday after the provider of cancer-fighting treatments reported a pha...

August 28, 2023, 5:25 pm

Why is novocure (nvcr) stock down 30% today?

Shares of innovative biotechnology firm Novocure (NASDAQ: NVCR ) cratered badly, losing 30% on Monday morning before fading even further in the early ...

August 28, 2023, 2:53 pm

Why novocure stock is crashing today

NovoCure's tumor treating fields therapy didn't meet the primary endpoint in a phase 3 study targeting ...

August 28, 2023, 12:21 pm

Novocure stock plummets after phase 3 cancer trial fails to reach desired endpoint

Novocure (NASDAQ:NVCR) shares are down nearly a third Monday after a phase 3 study of its Tumor Treatin...

August 28, 2023, 12:04 pm

Merck (mrk), eisai to end keytruda-lenvima combo cancer study

With the phase III LEAP-010 study failing to show an overall survival benefit for patients with recurre...

August 28, 2023, 12:02 pm

Onl therapeutics completes enrollment in phase 2 study of first-in-class fas-inhibitor in patients with macula-off rhegmatogenous retinal detachment

More than 135 patients recruited in four months for phase 2 study of a single intravitreal (IVT) inject...

August 28, 2023, 11:00 am

Gain therapeutics presents new preclinical data demonstrating a reduction of plasma neurodegeneration biomarker nfl after administration of its drug candidate gt-02287 in gba1 parkinson’s disease mode

Treatment with GT-02287 also restored glucocerebrosidase (GCase) enzymatic function, reduced aggregated α-synuclein, neuroinflammation and neuronal d...

August 28, 2023, 11:00 am

Enphase energy, inc. (enph) is a trending stock: facts to know before betting on it

Zacks.com users have recently been watching Enphase Energy (ENPH) quite a bit. Thus, it is worth knowin...

August 28, 2023, 10:32 am

5 computer vision stocks with a clear path to growth

AI is hot; today's craze is just the tip of the iceberg. While large language models, generative AI, and image-producing algorithms are neat, the next...

August 28, 2023, 9:48 am

Manchester united: assessing takeover potential amid market buzz

Manchester United is currently in the midst of takeover discussions, with two notable offers on the table. INEOS' phased takeover offer is still on th...

August 28, 2023, 8:42 am

Torr metals mobilizes field crews to latham project in bc's golden triangle

Torr Metals (TSX-V:TMET) told investors it has commenced its 2023 surface exploration program on its 100%-owned 689 square kilometre Latham copper-gol...

August 28, 2023, 8:17 am

Aud/usd technical: potential minor countertrend rebound in progress

Medium-term downtrend phase of AUD/USD has reached an oversold condition with downside momentum easing....

August 28, 2023, 7:08 am

Aud/usd technical: potential minor countertrend rebound in progress

Medium-term downtrend phase of AUD/USD has reached an oversold condition with downside momentum easing....

August 28, 2023, 5:01 am

Icymi - jp morgan see limited downside for crypto markets over the near term

A report from JPM late last week says the downside shift for Bitcoin looks to be ending. JPM cite their analysis of open interest in Chicago Mercantil...

August 28, 2023, 3:52 am

Selnoflast by f. hoffmann-la roche for coronary artery disease (cad) (ischemic heart disease): likelihood of approval

Selnoflast is under clinical development by F. Hoffmann-La Roche and currently in phase I for Coronary ...

August 28, 2023, 3:44 am

Audusd daily analysis – august 28, 2023

AUDUSD currently finds itself in a phase of sideways consolidation, operating within the confines of a ...

August 28, 2023, 12:31 am

Bridgebio presents detailed positive results from phase 3 attribute-cm study of acoramidis for patients with transthyretin amyloid cardiomyopathy (attr-cm) at european society of cardiology congress 2

– The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consisten...

August 27, 2023, 10:15 am


Search within

Pages Search Results: